Cargando…
VEGF-A isoform modulation in an preclinical TNBS model of ulcerative colitis: protective effects of a VEGF164(b) therapy
BACKGROUND: Ulcerative colitis (UC) is the most common form of inflammatory bowel disease in the USA. A key component of UC is the increase in inflammatory angiogenesis of the colon during active disease. This increase is driven to a great extent by the over expression of VEGF-A. Recently, VEGF165(b...
Autores principales: | Cromer, Walter E, Ganta, Chaitanya V, Patel, Mihir, Traylor, James, Kevil, Christopher G, Alexander, J Steven, Mathis, J Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3848761/ https://www.ncbi.nlm.nih.gov/pubmed/24020796 http://dx.doi.org/10.1186/1479-5876-11-207 |
Ejemplares similares
-
VEGF(121)b and VEGF(165)b are weakly angiogenic isoforms of VEGF-A
por: Catena, Raúl, et al.
Publicado: (2010) -
Expression of VEGF(xxx)b, the inhibitory isoforms of VEGF, in malignant melanoma
por: Pritchard-Jones, R O, et al.
Publicado: (2007) -
Mechanism by which oleracein E alleviates TNBS-induced ulcerative colitis
por: Huang, Yun, et al.
Publicado: (2023) -
Potential Dual Immunomodulatory Role of VEGF in Ulcerative Colitis and Colorectal Carcinoma
por: Zdravkovic, Natasa D, et al.
Publicado: (2014) -
VEGF(164)-mediated Inflammation Is Required for Pathological, but Not Physiological, Ischemia-induced Retinal Neovascularization
por: Ishida, Susumu, et al.
Publicado: (2003)